(Press-News.org) Vanderbilt University researchers studying interventions for adolescents and young adults with autism are reporting today that there is insufficient evidence to support findings, good or bad, for the therapies currently used.
Although the prevalence of autism is on the rise, much remains to be discovered when it comes to interventions for this population, the researchers concluded.
"Overall, there is very little evidence in all areas of care for adolescents and young adults with autism, and it is urgent that more rigorous studies be developed and conducted," said Melissa McPheeters, Ph.D., M.P.H., director of Vanderbilt's Evidence-Based Practice Center and senior author of the report, a systematic review of therapies published by the Department of Health and Human Services' Agency for Healthcare Research and Quality (AHRQ).
Zachary Warren, Ph.D., director of the Vanderbilt Kennedy Center's Treatment and Research Institute for Autism Spectrum Disorders, said, "There are growing numbers of adolescents and adults with autism in need of substantial support. Without a stronger evidence base, it is very hard to know which interventions will yield the most meaningful outcomes for individuals with autism and their families."
Key findings:
The researchers systematically screened more than 4,500 studies and reviewed the 32 studies published from January 1980 to December 2011 on therapies for people ages 13 to 30 with autism spectrum disorders. They focused on the outcomes, including harms and adverse effects, of interventions, including medical, behavioral, educational and vocational.
Some evidence revealed that treatments could improve social skills and educational outcomes such as vocabulary or reading, but the studies were generally small and had limited follow-up.
Limited evidence supports the use of medical interventions in adolescents and young adults with autism. The most consistent findings were identified for the effects of antipsychotic medications on reducing problem behaviors that tend to occur with autism, such as irritability and aggression. Harms associated with medications included sedation and weight gain.
Only five articles tested vocational interventions, all of which suggested that certain vocational interventions may be effective for certain individuals, but each study had significant flaws that limited the researchers' confidence in their conclusions. The researchers' findings on vocational interventions will be featured in the Aug. 27 issue of Pediatrics.
As recently as the 1970s, autism was believed to affect just one in 2,000 children, but newly released data from the Centers for Disease Control and Prevention (CDC) estimates that one in 88 children has an autism spectrum disorder. Boys with autism outnumber girls 5-to-1, which estimates that one in 54 boys in the United States have autism.
"With more and more youth with autism leaving high school and entering the adult world, there is urgent need for evidence-based interventions that can improve their quality of life and functioning," said Julie Lounds Taylor, Ph.D., assistant professor of Pediatrics and Special Education and lead author of the report.
###
Additional investigators on this report include Jeremy Veenstra-VanderWeele, M.D., assistant professor of Psychiatry, Pediatrics and Pharmacology and Kennedy Center investigator; Dwayne Dove, M.D., Ph.D., fellow in Developmental-Behavioral Pediatrics; Nila Sathe, M.S., M.L.I.S., program manager, Institute for Medicine and Public Health; and Rebecca Jerome, M.L.I.S., M.P.H., assistant director, Eskind Biomedical Library.
Their research, published in the report, Interventions for Adolescents and Young Adults with Autism Spectrum Disorders, was funded by the Agency for Healthcare Research and Quality's Effective Health Care Program and conducted through Vanderbilt's Evidence-Based Practice Center.
Little evidence supports autism treatment options in adolescents
2012-08-27
ELSE PRESS RELEASES FROM THIS DATE:
Arctic sea ice reaches lowest extent ever recorded, says CU-Boulder research team
2012-08-27
The blanket of sea ice floating on the Arctic Ocean melted to its lowest extent ever recorded since satellites began measuring it in 1979, according to the University of Colorado Boulder's National Snow and Ice Data Center.
On Aug. 26, the Arctic sea ice extent fell to 1.58 million square miles, or 4.10 million square kilometers. The number is 27,000 square miles, or 70,000 square kilometers below the record low daily sea ice extent set Sept. 18, 2007. Since the summer Arctic sea ice minimum normally does not occur until the melt season ends in mid- to-late September, ...
Special international commission on media violence confirms aggression link
2012-08-27
AMES, Iowa -- As president of the International Society for Research on Aggression (IRSA) and with consent of the organization's elected council, Craig Anderson appointed an international Media Violence Commission last December to prepare a public statement on the known effects of media violence exposure, based on the current state of scientific knowledge. The Iowa State University Distinguished Professor of psychology appointed 12 IRSA researchers to the commission, including Douglas Gentile, an ISU associate professor of psychology.
The Media Violence Commission's research-based ...
CancerMedsCanada.com Partners with Great Canadian Pharmacy to Provide Cost-Effective Prescription Drugs Online
2012-08-27
CancerMeds Canada is an affiliate for a well-known leading global pharmacy intermediary GreatCanadianPharmacy.com. "Since 2004, our goal at GreatCanadianPharmacy.com is to provide consumers affordable Canada drugs through our unique network of licensed global pharmacies and Canadian pharmacies," explains the owner of CancerMedsCanada.com, Thomas Unger. "We aim to be one of the forerunners of premier prescription fulfillment service providers on the Web."
GreatCanadianPharmacy.com offers the cheapest and best drug prices for its consumers on the Web. ...
Mayo, UCSF team discovers genomic variant that increases risk of brain tumors
2012-08-27
ROCHESTER, Minn. -- People who carry a "G" instead of an "A" at a specific spot in their genetic code have roughly a six-fold higher risk of developing certain types of brain tumors, a Mayo Clinic and University of California, San Francisco study has found. The findings, published online today in the journal Nature Genetics, could help researchers identify people at risk of developing certain subtypes of gliomas which account for about 20 percent of new brain cancers diagnosed annually in the U.S. and may lead to better surveillance, diagnosis and treatment.
Researchers ...
UCSF, Mayo team discovers genomic variant that increases risk of some brain tumors
2012-08-27
People who carry a "G" instead of an "A" at a specific spot in the sequence of their genetic code have roughly a six-fold higher risk of developing certain types of brain tumors, according to a study by researchers at the University of California, San Francisco and Mayo Clinic.
The study was jointly led by geneticists Margaret Wrensch, PhD, and John Wiencke, PhD, professors in the Department of Neurological Surgery at UCSF, and Robert Jenkins, MD, PhD, professor of Laboratory Medicine in the Department of Laboratory Medicine and Pathology and the Division of Laboratory ...
New wave of technologies possible after ground-breaking analysis tool developed
2012-08-27
A revolutionary tool created by scientists at the University of Sheffield has enabled researchers to analyse nanometer-sized devices without destroying them for the first time, opening the door to a new wave of technologies.
The nuclear magnetic resonance apparatus – developed by the University's Department of Physics and Astronomy – will allow for further developments and new applications for nanotechnology which is increasingly used in harvesting solar energy, computing, communication developments and also in the medical field.
Scientists can now analyse nanostructures ...
A lesson in sleep learning
2012-08-27
Is sleep learning possible? A new Weizmann Institute study appearing today in Nature Neuroscience has found that if certain odors are presented after tones during sleep, people will start sniffing when they hear the tones alone – even when no odor is present – both during sleep and, later, when awake. In other words, people can learn new information while they sleep, and this can unconsciously modify their waking behavior.
Sleep-learning experiments are notoriously difficult to conduct. For one thing, one must be sure that the subjects are actually asleep and stay that ...
Weighing molecules 1 at a time
2012-08-27
PASADENA, Calif.—A team led by scientists at the California Institute of Technology (Caltech) have made the first-ever mechanical device that can measure the mass of individual molecules one at a time.
This new technology, the researchers say, will eventually help doctors diagnose diseases, enable biologists to study viruses and probe the molecular machinery of cells, and even allow scientists to better measure nanoparticles and air pollution.
The team includes researchers from the Kavli Nanoscience Institute at Caltech and Commissariat à l'Energie Atomique et aux ...
Controlling gene expression: How chromatin remodelers block a histone pass
2012-08-27
KANSAS CITY, MO—Two opposing teams battle it out to regulate gene expression on the DNA playing field. One, the activators, keeps DNA open to enzymes that transcribe DNA into RNA. Their repressor opponents antagonize that effort by twisting DNA into an inaccessible coil around histone proteins, an amalgam called chromatin, effectively blocking access to DNA by enzymes that elongate an RNA strand.
Both teams maneuver by chemically modifying histones—the activators by decorating histones with acetyl groups—let's call them green flags—causing them to loosen their grip on ...
Compound discovered that boosts effect of vaccines against HIV and flu
2012-08-27
Oxford University scientists have discovered a compound that greatly boosts the effect of vaccines against viruses like flu, HIV and herpes in mice.
An 'adjuvant' is a substance added to a vaccine to enhance the immune response and offer better protection against infection.
The Oxford University team, along with Swedish and US colleagues, have shown that a type of polymer called polyethyleneimine (PEI) is a potent adjuvant for test vaccines against HIV, flu and herpes when given in mice.
The researchers were part-funded by the UK Medical Research Council and report ...